Improvement of endothelial and renal function with combination of an angiotensin II receptor blocker and statin in hypertensive patients with dyslipidemia

被引：0
|
作者：
Villevalde, S. [1 ]
Mirilashvili, T. [1 ]
Kotovskaya, Y. [1 ]
Kobalava, Z. [1 ]
机构：
[1] Russian Peoples Frienship Univ, Moscow, Russia
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S527 / S527
页数：1
相关论文
共 50 条
  • [1] Improvement of renal function by angiotensin II receptor blocker in patients with essential hypertension
    Watanabe, S
    Okura, T
    Takata, Y
    Miyoshi, K
    Higaki, J
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 103A - 103A
  • [2] Telmisartan, an angiotensin II type 1 receptor blocker, improves endothelial function in essential untreated hypertensive patients
    Svolis, K
    Svolis, A
    Lemboussi, D
    Loukopoulou, P
    Patronis, A
    Bakopoulos, C
    Stellas, L
    JOURNAL OF HYPERTENSION, 2004, 22 : S194 - S194
  • [3] Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients
    Doi, Masayuki
    Miyoshi, Toru
    Hirohata, Satoshi
    Kamikawa, Shigeshi
    Usui, Shinichi
    Kaji, Youko
    Sakane, Kosuke
    Ogawa, Hiroko
    Ninomiya, Yoshifumi
    Kusachi, Shozo
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (05): : 433 - 439
  • [4] Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
    Koh, KK
    Ahn, JY
    Han, SH
    Kim, DS
    Jin, DK
    Kim, HS
    Shin, MS
    Ahn, TH
    Choi, IS
    Shin, EK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) : 905 - 910
  • [5] Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation
    Kario, Kazuomi
    Hoshide, Satoshi
    Uchiyama, Kazuaki
    Yoshida, Tetsuro
    Okazaki, Osamu
    Noshiro, Takao
    Aoki, Hirotaka
    Mizuno, Hiroyuki
    Matsumoto, Yuri
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (10): : 1036 - 1044
  • [6] Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD
    Suzuki, H
    Kanno, Y
    Sugahara, S
    Okada, H
    Nakamoto, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (06) : 1056 - 1064
  • [7] Renal Protective Effect in Hypertensive Patients: The High Doses of Angiotensin II Receptor Blocker (HARB) Study
    Mitsuru Ohishi
    Takashi Takagi
    Norihisa Ito
    Yuji Tatara
    Norihiro Hayashi
    Atsushi Shiota
    Yoshihiro Iwamoto
    Tomohiro Katsuya
    Hiromi Rakugi
    Toshio Ogihara
    Hypertension Research, 2007, 30 : 1187 - 1192
  • [8] Renal protective effect in hypertensive patients: The high doses of angiotensin II receptor blocker (HARB) study
    Ohishi, Mitsuru
    Takagi, Takashi
    Ito, Norihisa
    Tatara, Yuji
    Hayashi, Norihiro
    Shiota, Atsushi
    Iwamoto, Yoshihiro
    Katsuya, Tornohiro
    Rakugi, Hiromi
    Ogihara, Toshio
    HYPERTENSION RESEARCH, 2007, 30 (12) : 1187 - 1192
  • [9] Renoprotective effect of a calcium channel blocker, benidipine, in combination with an angiotensin II receptor blocker in hypertensive patients with chronic kidney disease
    Dohi, Y.
    Miyagawa, K.
    Nakazawa, A.
    Kimura, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S515 - S515
  • [10] Beneficial Effects of Combination Therapy with Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor on Vascular Endothelial Function
    Satoshi Morimoto
    Kei Maki
    Yasuko Aota
    Takao Sakuma
    Toshiji Iwasaka
    Hypertension Research, 2008, 31 : 1603 - 1610
12345